# US 10,945,957 B2 · Biodegradable nano-theranostic composite and process of preparation thereof > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 10,945,957 B2 - Document ID: US10945957B2 - Status: Granted - Kind: B2 - Application number: 16/483,897 - Filed: 2018-02-09 - Published: 2020-07-30 - Granted: 2021-03-16 - Earliest claimed: 2017-02-10 - Assignees: Council of Scientific and Industrial Research - Applicants: Council of Scientific & Industrial Research - Inventors: Selvaraj Kaliaperumal; Rajendra Prasad - Web page: https://patentgrep.com/patent/US10945957B2 ## CPC - A61K 9/1277: Preparation processes; Proliposomes - A61K 47/02: Inorganic compounds - A61K 47/551: {one of the codrug's components being a vitamin, e.g. niacinamide, vitamin B3, cobalamin, vitamin B12, folate, vitamin A or retinoic acid} - A61K 47/6911: {the form being a liposome} - A61K 31/704: attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin {(digitoxin A61K31/7048)} - A61K 31/7105: Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links - A61K 31/711: Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links - A61K 41/0052: {Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy} - B82Y 5/00: Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery - A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D) - B82Y: SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES ## Abstract A biodegradable nano-theranostic composite comprising graphene oxide and lipid in the liposomes in the ration of 0.005 to 0.03 characterized in that the graphene oxide is coated as film on the liposome on the inner side and outer side of the liposome. The composite is capable of safely carrying sensitive cargo without premature release and is fluorescent and absorbs in the NIR region and can perform targeted combined chemo and photothermal therapy. The nanotheranostic nanocomposite is designed to collapse and biodegrade after use. ## Claims ### Claim 1 A biodegradable nano composite comprising graphene oxide and a lipid in a liposome in a ratio of 0.005 to 0.03 by weight, characterized in that the graphene oxide is coated as a film on an inner side and an outer side of the liposome, wherein said nano composite is functionalized. ### Claim 2 (depends on 1) The nano composite as claimed in claim 1, wherein said nano composite is fluorescent and absorbs in the near-infrared region. ### Claim 3 (depends on 1) A composition comprising the nano composite as claimed in claim 1, along with a cargo selected from the group consisting of a drug, a biomolecule and a dye. ### Claim 4 (depends on 3) The composition as claimed in claim 3, wherein the drug in the cargo is Doxorubicin and the biomolecule is Deoxyribonucleic acid or Ribonucleic acid. ### Claim 5 (depends on 1) A process for the synthesis of the nano composite as claimed in claim 1, wherein said process comprises the steps of: a) dissolving the lipid in a volatile solvent to obtain a mixture; b) removing of the volatile solvent from the mixture obtained in step (a), followed by adding phosphate-buffered saline containing fluorescent graphene oxide nanoflakes in an amount in the range of 0.5 to 3 mg, to obtain a lipid suspension in the form of multilamellar vesicles during film hydration process; and c) extruding the suspension of multilamellar vesicles as obtained in step (b) at a transition temperature in the range of 40 to 50° C. of the lipid using an extruder with polycarbonate membranes to form said biodegradable nano composite. ### Claim 6 (depends on 5) The process as claimed in claim 5, wherein said lipid is selected from the group consisting of L-alpha-dipalmitoylphosphatidylcholine, 1,2-Dimyristoyl-sn-glycero-3-phosphorylcholine and 1,2-Dimyristoyl-sn-glycero-3-phosphorylglycerol sodium salt. ### Claim 7 (depends on 5) The process as claimed in claim 5, wherein said volatile solvent of step a) is selected from the group consisting of chloroform, and alcohol or mixtures thereof. ### Claim 8 (depends on 5) The process as claimed in claim 5, wherein said graphene oxide nanoflakes are synthesized by a process comprising the steps of: i) adding graphene oxide into a concentrated solution of sulfuric acid and nitric acid at volume ratio of 3.3 to 2.8 followed by stirring for a time period in the range of 12 to 14 h at a temperature in the range of 35 to 40° C. to afford a product; and ii) dialyzing the product of step i) at the temperature in the range of 35-40° C. by a dialysis bag having a molecular weight cut-off of 2000 Da for a period in the range of 2 to 4 days to afford the graphene oxide nanoflakes with specific emissions in the range of 600 to 850 nm. ### Claim 9 (depends on 1) A process for functionalization of the nano composite as claimed in claim 1 with a targeting ligand comprising the steps of: a) activating functional group of graphene oxide nanoflakes present on an external surface of the nano composite by 1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide/N-Hydroxysuccinimide agent followed by adding cystamine in a reaction mixture to obtain an amine functionalized nanocomposite; b) anchoring folic acid on the amine functionalized nanocomposite; c) mixing an aqueous solution of the amine functionalized nano composite with activated folic acid and reacting for 12 hours; and d) dialyzing the mixture of step c) using a dialysis bag having a molecular weight cut-off of 2000 Da for a period in the range of 6 to 48 hours to obtain functionalized nano composite. ### Claim 10 (depends on 9) The process as claimed in claim 9, wherein said process is carried out at a temperature in the range of 37° C. to 40° C.